HOTAIR and DNMT1 levels were enhanced, PTEN expression was reduced and PTEN methylation was enhanced in bone marrow of CML patients (all P < 0.05) (Fig. 1A–F). This evidence concerns the gene PTEN and chronic myelogenous leukemia, BCR-ABL1 positive.